Impact of Neoadjuvant Chemotherapy Combined With Modified Radical Mastectomy on Immune Function, Oxidative Stress, and Prognosis in Patients With Different Molecular Subtypes of Breast Cancer
Einfluss neoadjuvanter Chemotherapie kombiniert mit modifizierter radikaler Mastektomie auf Immunfunktion, oxidativen Stress und Prognose bei Patient:innen mit unterschiedlichen molekularen Subtypen von Brustkrebs
Annali Italiani di Chirurgia · 10.11.2025 · 96 (11)
DOI: 10.62713/aic.4263 ↗Auf einen Blick
Bei 150 Patient:innen mit Brustkrebs war der HER-2-Überexpressionssubtyp mit kürzerem rezidivfreiem Überleben verbunden. Unterschiede im Gesamtüberleben zwischen den vier Subtypen zeigten sich nicht.
Fragestellung
Welchen Einfluss hat neoadjuvante Chemotherapie kombiniert mit modifizierter radikaler Mastektomie auf Immunfunktion, oxidativen Stress und Prognose bei verschiedenen molekularen Subtypen von Brustkrebs?
Methode
Retrospektive Analyse von 150 Patient:innen mit Brustkrebs nach NACT und modifizierter radikaler Mastektomie; Einteilung in 4 molekulare Subtypen; Erfassung von pCR, Rezidiv, RFS, OS sowie MDA, SOD, IL-6, IL-8 und TNF-α.
Ergebnisse
pCR gesamt 20,67 %; Rezidivrate im Follow-up 22,67 %. HER-2-Überexpression: pCR 38,24 %, Rezidiv 38,24 %, kürzeres RFS; HR für RFS 3,883 (95 %-KI 1,371–11,004). Für OS unterschieden sich die Gruppen nicht signifikant.
Schlussfolgerung der Autor:innen
Bei Brustkrebs unter NACT plus modifizierter radikaler Mastektomie war der HER-2-Überexpressionssubtyp mit kürzerem RFS verbunden. Beim OS zeigten sich während des Follow-ups keine signifikanten Unterschiede zwischen den vier Subtypen.
Kernaussagen
- HER-2-Überexpression: kürzeres RFS
- OS zwischen 4 Subtypen nicht signifikant verschieden
- Entzündungs- und Oxidationsmarker nach 3 Monaten verbessert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Annali Italiani di Chirurgia, online erschienen am 10.11.2025. Verfasst von Danxia Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, The People's Hospital of Danyang, 212300 Danyang, Jiangsu, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Oxidative Stress, Breast Neoplasms, Mastectomy, Modified Radical. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
AIM: The objective of this study is to explore the impact of neoadjuvant chemotherapy (NACT) combined with modified radical mastectomy on immune function, oxidative stress and prognosis in patients with different molecular subtypes of breast cancer (BC). METHODS: A total of 150 patients diagnosed with BC who received NACT and modified radical mastectomy from January 2020 to January 2024 were collected for retrospective analysis. All patients were divided into four groups according to the molecular subtype: luminal A group (n = 39), luminal B group (n = 44), human epidermal growth factor receptor 2 (HER-2) overexpression group (n = 34), and triple-negative group (n = 33). Data on pathological complete remission (pCR), recurrence, recurrence-free survival (RFS) and overall survival (OS) were collected. The serum levels of malondialdehyde (MDA), superoxide dismutase (SOD), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor alpha (TNF-α) were detected using assay kits. RESULTS: The pCR rate of the entire sample cohort was 20.67% after NACT, with a recurrence rate during follow-up recorded at 22.67%. The pCR rate was significantly higher in the HER-2 overexpression group (13/34, 38.24%) than in the triple-negative (11/33, 33.33%), luminal A (1/39, 2.56%), and luminal B groups (6/44, 13.64%) (p < 0.001). Compared to the triple-negative (10/33, 30.30%), luminal A (5/39, 12.82%), and luminal B groups (6/44, 13.64%), the HER-2 overexpression group (13/34, 38.24%) had a significantly higher recurrence rate (p = 0.019). Both HER-2 overexpression and triple-negative groups also featured greater changes in IL-6, TNF-α, and SOD levels than the luminal A and luminal B groups (p < 0.05). Changes in MDA levels were the greatest in the HER-2 overexpression group among the tested group (p < 0.05). HER-2 overexpression was identified as the independent risk factor affecting RFS (hazard ratio [HR] = 3.883; 95% confidence interval [CI] = 1.371–11.004; p = 0.011). Clinical stage III (HR = 2.031; 95% CI = 1.023–4.030; p = 0.043), pCR (HR = 0.111; 95% CI = 0.015–0.809; p = 0.030) and recurrence (HR = 4.512; 95% CI = 2.412–8.441; p < 0.001) were the independent factors affecting OS in BC patients. The Kaplan–Meier curve analysis demonstrated significant differences in RFS among the four patient groups (p = 0.005), with no marked differences in OS (p = 0.303). The RFS of the HER-2 overexpression group was shorter than that of the other groups. CONCLUSIONS: In BC patients undergoing NACT combined with modified radical mastectomy, the HER-2 overexpression subtype was associated with a shorter RFS. However, no significant differences in OS were observed among the four molecular subtypes during the follow-up period. Inflammatory and oxidative stress markers showed improvements three months postoperatively across all subtypes, with more pronounced changes observed in the HER-2 overexpression and triple-negative subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid and Breast Surgery, The People's Hospital of Danyang, 212300 Danyang, Jiangsu, China.
Zitieren
APA
Cao, D., Sun, Y., & Pan, H. (2025). Impact of Neoadjuvant Chemotherapy Combined With Modified Radical Mastectomy on Immune Function, Oxidative Stress, and Prognosis in Patients With Different Molecular Subtypes of Breast Cancer. Annali Italiani di Chirurgia, 96(11). https://doi.org/10.62713/aic.4263
Vancouver
Cao D, Sun Y, Pan H. Impact of Neoadjuvant Chemotherapy Combined With Modified Radical Mastectomy on Immune Function, Oxidative Stress, and Prognosis in Patients With Different Molecular Subtypes of Breast Cancer. Annali Italiani di Chirurgia. 2025;96(11). doi:10.62713/aic.4263
BibTeX
@article{Cao2025,
author = {Cao, Danxia and Sun, Yi and Pan, Hongying},
title = {Impact of Neoadjuvant Chemotherapy Combined With Modified Radical Mastectomy on Immune Function, Oxidative Stress, and Prognosis in Patients With Different Molecular Subtypes of Breast Cancer},
journal = {Annali Italiani di Chirurgia},
year = {2025},
volume = {96},
number = {11},
doi = {10.62713/aic.4263}
}
EUVIMED